FDA Inspection
Amgen Singapore Manufacturing Pte LtdAmgen Singapore Manufacturing Pte Ltd – FDA Inspection, Jan 29, 2019
Record Details
This FDA Inspection record concerns Amgen Singapore Manufacturing Pte Ltd, with an inspection on January 29, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- Person
- Zhihao Pete Qiu (Issuing Officer)
View Company Profile
ID · 66272d25-6097-4632-9426-c931264f8f6a
Inspection Facts
- Inspection number
- 1079136
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Amgen Singapore Manufacturing Pte Ltd
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2024 | Not classified | Office of Inspections and Investigations | |
| October 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2019 | Not classified | Office of Inspections and Investigations | |
| May 25, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Amgen Singapore Manufacturing Pte Ltd
- FDA Inspection 1244897 - 2024-05-14
- FDA Inspection 1112149 - 2019-10-25
- FDA Inspection 1082474 - 2019-01-18
- FDA Inspection 1060510 - 2018-05-25
- FDA Inspection 998776 - 2017-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.